Srinivas Ayyadevara
Concepts (291)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Caenorhabditis elegans | 29 | 2024 | 138 | 5.610 |
Why?
| Alzheimer Disease | 9 | 2024 | 317 | 2.780 |
Why?
| Longevity | 13 | 2019 | 80 | 2.410 |
Why?
| Caenorhabditis elegans Proteins | 12 | 2019 | 56 | 2.100 |
Why?
| Neurodegenerative Diseases | 4 | 2022 | 76 | 1.930 |
Why?
| Phosphatidylinositol 3-Kinases | 6 | 2016 | 141 | 1.380 |
Why?
| Aging | 5 | 2016 | 688 | 1.290 |
Why?
| Phosphatidylinositol Phosphates | 3 | 2018 | 15 | 1.230 |
Why?
| Aspirin | 3 | 2017 | 114 | 1.010 |
Why?
| 14-3-3 Proteins | 2 | 2022 | 18 | 1.000 |
Why?
| Animals | 37 | 2024 | 13150 | 0.890 |
Why?
| Oxidative Stress | 6 | 2012 | 768 | 0.890 |
Why?
| Creutzfeldt-Jakob Syndrome | 1 | 2022 | 7 | 0.860 |
Why?
| DNA | 3 | 2021 | 545 | 0.780 |
Why?
| Peptide Chain Elongation, Translational | 1 | 2021 | 7 | 0.770 |
Why?
| Glutathione Transferase | 3 | 2006 | 174 | 0.770 |
Why?
| RNA | 1 | 2021 | 170 | 0.710 |
Why?
| Chromosome Mapping | 4 | 2006 | 160 | 0.710 |
Why?
| RNA Interference | 7 | 2016 | 179 | 0.690 |
Why?
| Proteomics | 3 | 2018 | 328 | 0.670 |
Why?
| Somatomedins | 1 | 2018 | 32 | 0.650 |
Why?
| Hippocampus | 2 | 2021 | 228 | 0.640 |
Why?
| Mutation | 6 | 2016 | 1293 | 0.630 |
Why?
| Membrane Proteins | 3 | 2018 | 342 | 0.620 |
Why?
| Proteins | 2 | 2018 | 341 | 0.610 |
Why?
| Phosphatidylinositol 4,5-Diphosphate | 1 | 2016 | 10 | 0.560 |
Why?
| Muscles | 1 | 2016 | 103 | 0.550 |
Why?
| Insulin | 1 | 2018 | 457 | 0.540 |
Why?
| Aldehydes | 2 | 2006 | 83 | 0.530 |
Why?
| Proteasome Endopeptidase Complex | 2 | 2018 | 114 | 0.500 |
Why?
| Amyloid beta-Peptides | 4 | 2021 | 69 | 0.500 |
Why?
| Quantitative Trait Loci | 2 | 2006 | 42 | 0.500 |
Why?
| Lipids | 2 | 2016 | 147 | 0.490 |
Why?
| Proteasome Inhibitors | 1 | 2014 | 104 | 0.460 |
Why?
| Brain | 2 | 2018 | 1309 | 0.450 |
Why?
| Gene Knockdown Techniques | 3 | 2016 | 106 | 0.400 |
Why?
| Hypertension | 1 | 2016 | 532 | 0.370 |
Why?
| Animals, Genetically Modified | 4 | 2018 | 49 | 0.370 |
Why?
| Cardiovascular Diseases | 1 | 2016 | 440 | 0.370 |
Why?
| Peptide Fragments | 3 | 2021 | 216 | 0.360 |
Why?
| Autophagy | 3 | 2024 | 168 | 0.360 |
Why?
| Obesity | 1 | 2018 | 1113 | 0.360 |
Why?
| Signal Transduction | 4 | 2018 | 1617 | 0.330 |
Why?
| Polymerase Chain Reaction | 2 | 2000 | 455 | 0.330 |
Why?
| Lipid Peroxidation | 2 | 2007 | 100 | 0.330 |
Why?
| Humans | 22 | 2022 | 49827 | 0.320 |
Why?
| Gene Expression Regulation | 3 | 2011 | 979 | 0.320 |
Why?
| Codon, Nonsense | 3 | 2016 | 26 | 0.310 |
Why?
| Protein Binding | 4 | 2018 | 660 | 0.310 |
Why?
| Disease Models, Animal | 6 | 2021 | 1451 | 0.280 |
Why?
| Genetic Markers | 3 | 2003 | 103 | 0.280 |
Why?
| Transcription, Genetic | 5 | 2015 | 371 | 0.280 |
Why?
| Molecular Dynamics Simulation | 2 | 2017 | 33 | 0.270 |
Why?
| Receptor, Insulin | 1 | 2005 | 41 | 0.260 |
Why?
| Growth Inhibitors | 1 | 2005 | 27 | 0.260 |
Why?
| Phosphorylation | 2 | 2017 | 536 | 0.260 |
Why?
| Lysosomes | 3 | 2024 | 64 | 0.250 |
Why?
| Cell Death | 2 | 2016 | 181 | 0.250 |
Why?
| Kidney Tubules | 2 | 2017 | 60 | 0.240 |
Why?
| Quantitative Trait, Heritable | 2 | 2001 | 16 | 0.240 |
Why?
| Cryoprotective Agents | 1 | 2024 | 6 | 0.240 |
Why?
| Cryopreservation | 1 | 2024 | 30 | 0.230 |
Why?
| Hydrogen Peroxide | 2 | 2016 | 114 | 0.220 |
Why?
| Amino Acid Sequence | 2 | 2021 | 587 | 0.210 |
Why?
| Apolipoprotein E4 | 2 | 2024 | 19 | 0.210 |
Why?
| Benzylamines | 1 | 2021 | 15 | 0.200 |
Why?
| Huntington Disease | 1 | 2021 | 23 | 0.200 |
Why?
| Microscopy, Fluorescence | 2 | 2012 | 162 | 0.200 |
Why?
| Cholinesterase Inhibitors | 1 | 2021 | 26 | 0.200 |
Why?
| Alkaloids | 1 | 2021 | 32 | 0.190 |
Why?
| Protein Folding | 1 | 2021 | 49 | 0.190 |
Why?
| Taq Polymerase | 1 | 2000 | 4 | 0.190 |
Why?
| Base Pair Mismatch | 1 | 2000 | 22 | 0.190 |
Why?
| Indoles | 2 | 2020 | 278 | 0.190 |
Why?
| Oxyquinoline | 1 | 2020 | 8 | 0.190 |
Why?
| Chelating Agents | 1 | 2020 | 27 | 0.180 |
Why?
| RNA, Viral | 1 | 2021 | 125 | 0.180 |
Why?
| Mice | 7 | 2024 | 5720 | 0.180 |
Why?
| Repetitive Sequences, Nucleic Acid | 1 | 2000 | 97 | 0.180 |
Why?
| Recombination, Genetic | 1 | 2001 | 108 | 0.180 |
Why?
| Neuroprotective Agents | 1 | 2021 | 105 | 0.180 |
Why?
| Glioma | 1 | 2021 | 79 | 0.180 |
Why?
| RNA-Binding Proteins | 1 | 2021 | 124 | 0.180 |
Why?
| Drug Design | 1 | 2020 | 120 | 0.170 |
Why?
| Proteome | 1 | 2021 | 173 | 0.170 |
Why?
| Models, Animal | 3 | 2019 | 233 | 0.170 |
Why?
| Hot Temperature | 2 | 2012 | 208 | 0.160 |
Why?
| Ubiquitin | 2 | 2018 | 45 | 0.160 |
Why?
| Computer Simulation | 2 | 2017 | 282 | 0.160 |
Why?
| Cells, Cultured | 4 | 2016 | 1571 | 0.160 |
Why?
| Gene Regulatory Networks | 1 | 2019 | 107 | 0.160 |
Why?
| DNA-Binding Proteins | 1 | 2021 | 436 | 0.150 |
Why?
| Forkhead Transcription Factors | 3 | 2009 | 112 | 0.150 |
Why?
| Cell Line | 2 | 2018 | 1002 | 0.150 |
Why?
| Intracellular Signaling Peptides and Proteins | 1 | 2018 | 142 | 0.150 |
Why?
| Nucleotide Motifs | 1 | 2017 | 24 | 0.150 |
Why?
| Genotype | 4 | 2017 | 538 | 0.150 |
Why?
| Replication Origin | 1 | 2017 | 11 | 0.150 |
Why?
| RNA, Transfer | 1 | 2017 | 16 | 0.150 |
Why?
| Telomerase | 1 | 2017 | 27 | 0.150 |
Why?
| Acetylation | 1 | 2017 | 99 | 0.150 |
Why?
| Complement C1q | 1 | 2017 | 9 | 0.140 |
Why?
| Pericytes | 1 | 2017 | 13 | 0.140 |
Why?
| Mice, Transgenic | 1 | 2018 | 555 | 0.140 |
Why?
| Complement C3 | 1 | 2017 | 24 | 0.140 |
Why?
| Carrier Proteins | 1 | 2018 | 304 | 0.140 |
Why?
| Young Adult | 2 | 2016 | 3936 | 0.140 |
Why?
| Transcriptome | 1 | 2019 | 313 | 0.140 |
Why?
| Complement Activation | 1 | 2017 | 42 | 0.140 |
Why?
| Intermediate Filament Proteins | 1 | 2016 | 12 | 0.140 |
Why?
| Detergents | 1 | 2016 | 16 | 0.140 |
Why?
| Thermodynamics | 1 | 2016 | 34 | 0.140 |
Why?
| tau Proteins | 1 | 2016 | 26 | 0.140 |
Why?
| Catalytic Domain | 1 | 2016 | 57 | 0.140 |
Why?
| DNA Replication | 1 | 2017 | 151 | 0.140 |
Why?
| Solubility | 1 | 2016 | 68 | 0.140 |
Why?
| DNA, Mitochondrial | 1 | 2017 | 112 | 0.140 |
Why?
| Promoter Regions, Genetic | 2 | 2011 | 477 | 0.140 |
Why?
| Blotting, Western | 2 | 2014 | 602 | 0.130 |
Why?
| Pyridinium Compounds | 1 | 2015 | 19 | 0.130 |
Why?
| Ligands | 1 | 2016 | 204 | 0.130 |
Why?
| Tissue Distribution | 1 | 2016 | 164 | 0.130 |
Why?
| Cyclin-Dependent Kinases | 1 | 2015 | 28 | 0.130 |
Why?
| Myofibroblasts | 1 | 2016 | 49 | 0.130 |
Why?
| Homologous Recombination | 1 | 2015 | 39 | 0.130 |
Why?
| Benzimidazoles | 1 | 2015 | 48 | 0.130 |
Why?
| Reference Values | 1 | 2016 | 310 | 0.130 |
Why?
| Peptide Nucleic Acids | 1 | 2015 | 17 | 0.130 |
Why?
| Rad51 Recombinase | 1 | 2015 | 21 | 0.130 |
Why?
| Antineoplastic Agents | 2 | 2015 | 1172 | 0.130 |
Why?
| Alleles | 2 | 2009 | 251 | 0.130 |
Why?
| Transcription Factors | 3 | 2009 | 563 | 0.120 |
Why?
| Fertility | 1 | 2014 | 28 | 0.120 |
Why?
| Fluorescent Antibody Technique | 1 | 2014 | 108 | 0.120 |
Why?
| Stress, Physiological | 3 | 2011 | 170 | 0.120 |
Why?
| Protein Multimerization | 1 | 2014 | 49 | 0.120 |
Why?
| Melphalan | 1 | 2015 | 174 | 0.120 |
Why?
| Kidney | 2 | 2024 | 665 | 0.120 |
Why?
| Genes, Helminth | 2 | 2006 | 5 | 0.120 |
Why?
| Macrophages | 1 | 2017 | 364 | 0.120 |
Why?
| Renal Insufficiency, Chronic | 1 | 2017 | 168 | 0.110 |
Why?
| Models, Molecular | 3 | 2020 | 337 | 0.110 |
Why?
| Case-Control Studies | 1 | 2016 | 1128 | 0.110 |
Why?
| Drug Resistance, Neoplasm | 1 | 2015 | 308 | 0.110 |
Why?
| Recombinant Fusion Proteins | 2 | 2021 | 182 | 0.110 |
Why?
| Age Factors | 1 | 2016 | 1090 | 0.110 |
Why?
| Life Expectancy | 1 | 2012 | 34 | 0.110 |
Why?
| Lipoprotein Lipase | 1 | 2012 | 12 | 0.100 |
Why?
| Endothelial Cells | 2 | 2011 | 269 | 0.100 |
Why?
| Locomotion | 1 | 2012 | 92 | 0.100 |
Why?
| Microscopy, Confocal | 1 | 2012 | 87 | 0.100 |
Why?
| Scavenger Receptors, Class E | 2 | 2011 | 204 | 0.100 |
Why?
| Fluorescent Dyes | 1 | 2012 | 101 | 0.100 |
Why?
| Down-Regulation | 2 | 2011 | 349 | 0.100 |
Why?
| Data Mining | 1 | 2011 | 40 | 0.100 |
Why?
| Triglycerides | 1 | 2012 | 159 | 0.100 |
Why?
| Antimitotic Agents | 1 | 2010 | 4 | 0.090 |
Why?
| Oxidants | 1 | 2011 | 53 | 0.090 |
Why?
| Apoptosis Regulatory Proteins | 1 | 2011 | 86 | 0.090 |
Why?
| Multiple Myeloma | 2 | 2015 | 2910 | 0.090 |
Why?
| Adult | 2 | 2016 | 13160 | 0.090 |
Why?
| Fatty Acids | 1 | 2011 | 143 | 0.090 |
Why?
| Cisplatin | 1 | 2012 | 278 | 0.090 |
Why?
| Histoplasma | 1 | 2009 | 27 | 0.090 |
Why?
| Lipoproteins, LDL | 1 | 2011 | 170 | 0.090 |
Why?
| Time Factors | 4 | 2019 | 2912 | 0.090 |
Why?
| Epistasis, Genetic | 2 | 2017 | 30 | 0.090 |
Why?
| Aged, 80 and over | 1 | 2016 | 3125 | 0.080 |
Why?
| Angiogenesis Inhibitors | 1 | 2010 | 187 | 0.080 |
Why?
| Histoplasmosis | 1 | 2009 | 50 | 0.080 |
Why?
| Gene Expression Regulation, Developmental | 2 | 2007 | 138 | 0.080 |
Why?
| Acute Kidney Injury | 1 | 2012 | 283 | 0.080 |
Why?
| Evolution, Molecular | 1 | 2009 | 99 | 0.080 |
Why?
| Atherosclerosis | 1 | 2011 | 214 | 0.080 |
Why?
| Gene Expression | 2 | 2012 | 608 | 0.080 |
Why?
| Binding Sites | 1 | 2009 | 377 | 0.080 |
Why?
| Survival Rate | 1 | 2011 | 905 | 0.080 |
Why?
| Oligonucleotide Array Sequence Analysis | 1 | 2009 | 412 | 0.080 |
Why?
| Oogenesis | 1 | 2007 | 16 | 0.080 |
Why?
| Oxygen | 1 | 2010 | 325 | 0.080 |
Why?
| Cell Proliferation | 1 | 2011 | 1007 | 0.070 |
Why?
| DNA Methylation | 1 | 2011 | 548 | 0.070 |
Why?
| Genes, Insect | 1 | 2006 | 11 | 0.070 |
Why?
| Male | 5 | 2018 | 25093 | 0.070 |
Why?
| Dose-Response Relationship, Drug | 2 | 2021 | 1374 | 0.070 |
Why?
| Drosophila melanogaster | 1 | 2006 | 30 | 0.070 |
Why?
| Environment | 1 | 2006 | 85 | 0.070 |
Why?
| Cell Line, Tumor | 3 | 2015 | 1402 | 0.070 |
Why?
| Models, Biological | 1 | 2009 | 728 | 0.070 |
Why?
| Apoptosis | 1 | 2011 | 1100 | 0.070 |
Why?
| Isoenzymes | 1 | 2005 | 168 | 0.060 |
Why?
| Xenograft Model Antitumor Assays | 2 | 2015 | 210 | 0.060 |
Why?
| Up-Regulation | 2 | 2011 | 450 | 0.060 |
Why?
| Stress, Psychological | 1 | 2006 | 260 | 0.060 |
Why?
| Gene Expression Regulation, Enzymologic | 1 | 2005 | 181 | 0.060 |
Why?
| Disease Progression | 2 | 2017 | 822 | 0.060 |
Why?
| Hormesis | 1 | 2024 | 8 | 0.060 |
Why?
| Vitrification | 1 | 2024 | 4 | 0.060 |
Why?
| Cytokines | 2 | 2017 | 612 | 0.060 |
Why?
| RNA, Messenger | 3 | 2017 | 1105 | 0.060 |
Why?
| Animals, Congenic | 1 | 2003 | 3 | 0.060 |
Why?
| Animals, Inbred Strains | 1 | 2003 | 5 | 0.060 |
Why?
| Aged | 1 | 2016 | 9272 | 0.060 |
Why?
| Saccharomyces cerevisiae | 1 | 2024 | 192 | 0.050 |
Why?
| Cell Survival | 2 | 2015 | 598 | 0.050 |
Why?
| Middle Aged | 1 | 2016 | 11997 | 0.050 |
Why?
| Electrophorus | 1 | 2021 | 5 | 0.050 |
Why?
| Butyrylcholinesterase | 1 | 2021 | 8 | 0.050 |
Why?
| Acetylcholinesterase | 1 | 2021 | 19 | 0.050 |
Why?
| Horses | 1 | 2021 | 44 | 0.050 |
Why?
| Phenotype | 2 | 2017 | 727 | 0.050 |
Why?
| Gene Expression Regulation, Neoplastic | 2 | 2015 | 829 | 0.050 |
Why?
| Crosses, Genetic | 1 | 2001 | 31 | 0.050 |
Why?
| Lasers | 1 | 2021 | 119 | 0.050 |
Why?
| Homozygote | 1 | 2001 | 56 | 0.050 |
Why?
| Biological Assay | 1 | 2021 | 45 | 0.050 |
Why?
| Heterozygote | 1 | 2001 | 82 | 0.050 |
Why?
| Templates, Genetic | 1 | 2000 | 14 | 0.050 |
Why?
| Chemistry Techniques, Synthetic | 1 | 2020 | 20 | 0.050 |
Why?
| Food Deprivation | 1 | 2000 | 29 | 0.050 |
Why?
| Peptides | 1 | 2021 | 222 | 0.050 |
Why?
| Molecular Structure | 1 | 2021 | 297 | 0.050 |
Why?
| Protein Structure, Secondary | 1 | 2020 | 72 | 0.050 |
Why?
| DNA Transposable Elements | 1 | 2000 | 107 | 0.050 |
Why?
| DNA Primers | 1 | 2000 | 206 | 0.040 |
Why?
| Polymorphism, Genetic | 1 | 2001 | 181 | 0.040 |
Why?
| Structure-Activity Relationship | 1 | 2021 | 394 | 0.040 |
Why?
| HEK293 Cells | 1 | 2020 | 222 | 0.040 |
Why?
| Anisomycin | 1 | 2019 | 3 | 0.040 |
Why?
| Dipyrone | 1 | 2019 | 3 | 0.040 |
Why?
| Camptothecin | 1 | 2019 | 16 | 0.040 |
Why?
| Benzazepines | 1 | 2019 | 19 | 0.040 |
Why?
| Azacitidine | 1 | 2019 | 34 | 0.040 |
Why?
| Protein Unfolding | 1 | 2018 | 6 | 0.040 |
Why?
| Protein Conformation | 1 | 2018 | 166 | 0.040 |
Why?
| Sensitivity and Specificity | 1 | 2000 | 854 | 0.040 |
Why?
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2017 | 13 | 0.040 |
Why?
| Apolipoprotein E3 | 1 | 2017 | 8 | 0.040 |
Why?
| Kaplan-Meier Estimate | 1 | 2019 | 469 | 0.040 |
Why?
| Cell Line, Transformed | 1 | 2017 | 72 | 0.040 |
Why?
| Electrophoretic Mobility Shift Assay | 1 | 2017 | 73 | 0.040 |
Why?
| Molecular Docking Simulation | 1 | 2017 | 73 | 0.040 |
Why?
| Wnt3A Protein | 1 | 2017 | 11 | 0.040 |
Why?
| Receptor, Platelet-Derived Growth Factor beta | 1 | 2017 | 20 | 0.040 |
Why?
| Extracellular Matrix Proteins | 1 | 2017 | 69 | 0.030 |
Why?
| Cell Communication | 1 | 2017 | 69 | 0.030 |
Why?
| Inflammation Mediators | 1 | 2017 | 112 | 0.030 |
Why?
| Fibrosis | 1 | 2017 | 178 | 0.030 |
Why?
| Ureteral Obstruction | 1 | 2017 | 60 | 0.030 |
Why?
| Indolizines | 1 | 2015 | 5 | 0.030 |
Why?
| Wnt Signaling Pathway | 1 | 2017 | 92 | 0.030 |
Why?
| Cyclic N-Oxides | 1 | 2015 | 12 | 0.030 |
Why?
| Folic Acid | 1 | 2017 | 135 | 0.030 |
Why?
| Drug Synergism | 1 | 2015 | 150 | 0.030 |
Why?
| Mice, SCID | 1 | 2015 | 175 | 0.030 |
Why?
| S Phase | 1 | 2015 | 19 | 0.030 |
Why?
| Genes, BRCA1 | 1 | 2015 | 19 | 0.030 |
Why?
| Mice, Knockout | 1 | 2017 | 841 | 0.030 |
Why?
| DNA Damage | 1 | 2015 | 301 | 0.030 |
Why?
| Receptors, Lipoprotein | 1 | 2012 | 7 | 0.030 |
Why?
| Azo Compounds | 1 | 2012 | 9 | 0.030 |
Why?
| Angiopoietins | 1 | 2012 | 5 | 0.030 |
Why?
| Peroxisome Proliferator-Activated Receptors | 1 | 2012 | 14 | 0.030 |
Why?
| Neutrophil Infiltration | 1 | 2012 | 26 | 0.030 |
Why?
| Coloring Agents | 1 | 2012 | 71 | 0.030 |
Why?
| Melanins | 1 | 2012 | 27 | 0.030 |
Why?
| Intracellular Space | 1 | 2012 | 25 | 0.030 |
Why?
| Adipose Tissue, White | 1 | 2012 | 34 | 0.030 |
Why?
| Necrosis | 1 | 2012 | 177 | 0.030 |
Why?
| Mice, Inbred C57BL | 1 | 2017 | 1806 | 0.020 |
Why?
| Intercellular Junctions | 1 | 2010 | 8 | 0.020 |
Why?
| Antibodies, Neutralizing | 1 | 2011 | 64 | 0.020 |
Why?
| Imaging, Three-Dimensional | 1 | 2012 | 149 | 0.020 |
Why?
| Cell Hypoxia | 1 | 2010 | 82 | 0.020 |
Why?
| Body Weight | 1 | 2012 | 513 | 0.020 |
Why?
| Analysis of Variance | 1 | 2011 | 565 | 0.020 |
Why?
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2015 | 987 | 0.020 |
Why?
| Microscopy | 1 | 2009 | 56 | 0.020 |
Why?
| Cell Differentiation | 1 | 2012 | 653 | 0.020 |
Why?
| Virulence | 1 | 2009 | 171 | 0.020 |
Why?
| Host-Pathogen Interactions | 1 | 2009 | 129 | 0.020 |
Why?
| Gene Expression Profiling | 1 | 2011 | 1031 | 0.020 |
Why?
| Liver | 1 | 2012 | 1109 | 0.020 |
Why?
| Female | 2 | 2017 | 26329 | 0.010 |
Why?
| Chromosomes, Artificial, Yeast | 1 | 2000 | 6 | 0.010 |
Why?
| Sequence Homology | 1 | 2000 | 20 | 0.010 |
Why?
| Larva | 1 | 2000 | 26 | 0.010 |
Why?
| Gene Library | 1 | 2000 | 44 | 0.010 |
Why?
| DNA, Complementary | 1 | 2000 | 135 | 0.010 |
Why?
| Cloning, Molecular | 1 | 2000 | 189 | 0.010 |
Why?
| Heat-Shock Proteins | 1 | 2000 | 99 | 0.010 |
Why?
|
|
Ayyadevara's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|